Thermo Fisher Scientific Envafolimab Humanized Recombinant Human Monoclonal Antibody

Thermo Fisher Scientific Envafolimab Humanized Recombinant Human Monoclonal Antibody

Applications

• ELISA (Assay-dependent)

Product Specifications

Product Specific Information

• Endotoxin level: < 0.01 EU/µg (LAL method)
• Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
• Store at 2–8°C for one week; at -20°C to -80°C for twelve months from date of receipt.

Target Information

Envafolimab (KN035) is the world’s first fusion protein combining a humanized anti-PD-L1 single-domain antibody and human IgG1 Fc.
Compared with PD-1/PD-L1 antibodies currently available or in development, it offers distinct advantages such as:

• Subcutaneous injection capability
• Stability at room temperature
• Rapid tumor penetration

These properties enhance patient compliance and quality of life, supporting long-term tumor management trends.

For Research Use Only.
Not for use in diagnostic procedures or resale without express authorization.